NEW YORK, Jan. 13, 2016 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Natural Health Trends Corp. (“Natural Health”) (NASDAQ:NHTC) between March 6, 2015 and January 12, 2016.
You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Central District of California. If you purchased or otherwise acquired Natural Health securities between March 6, 2015 and January 12, 2016, your rights may be affected by this action. To get more information go to: http://zlk.9nl.com/natural-health-trends-nhtc.
The complaint alleges that throughout the Class Period Defendants issued false and misleading statements to investors and/or failed to disclose that: (1) the operations of Natural Health Trends’ Chinese entity is not in compliance with applicable Chinese laws; and (2) as a result, Defendants’ statements about Natural Health Trends’ business, operations, and prospects, were false and misleading and/or lacked a reasonable basis at all relevant times.
If you suffered a loss in Natural Health you have until March 14, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/natural-health-trends-nhtc.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


Trump Administration Delays DeepSeek and CXMT Trade Blacklist Designations Amid U.S.-China Tensions
Hyundai to Acquire SoftBank’s Remaining Boston Dynamics Stake for $325 Million
Obayashi to Acquire Multiplex in $526M Expansion Deal
Meta Seeks Legal Shield From Child-Harm Lawsuits Amid KOSA Talks
SoftBank Shares Drop as OpenAI Losses and Rising Costs Spark Investor Concerns
BHP Shares Fall as Jansen Potash Project Costs Surge
SK Hynix Shares Hit Record High After Shipping Next-Generation HBM4E AI Memory Samples
GM and Lockheed Martin Partner to Strengthen U.S. Defense Manufacturing Capacity
Trump Says Anthropic No Longer Seen as National Security Threat
HSBC Australia Faces A$35M Penalty Over Scam Protection Failures
Jio IPO Filing Nears as Reliance Targets $4 Billion Market Debut
Apple Signals Product Price Hikes Amid Rising Memory Chip Costs
Qantas Nears Launch of World’s Longest Non-Stop Flights to London and New York
Microsoft Taps AWS to Support GitHub Amid AI Coding Boom
SpaceX Stock Slides After IPO Rally as Valuation Concerns Grow
TD Bank Expands Employee Monitoring Software to Boost Productivity Amid Privacy Concerns
Carro Expands Into Australia With Acquisition of Used-Car Platform CarPlace 



